nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Tamoxifen—pancreatic cancer	0.11	0.387	CbGbCtD
Tazarotene—CYP2C8—Erlotinib—pancreatic cancer	0.0936	0.329	CbGbCtD
Tazarotene—CYP2C8—Fluorouracil—pancreatic cancer	0.0811	0.285	CbGbCtD
Tazarotene—RARG—Nuclear Receptors—NR5A2—pancreatic cancer	0.0139	0.0473	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—NR5A2—pancreatic cancer	0.0125	0.0424	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR5A2—pancreatic cancer	0.012	0.0406	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR5A2—pancreatic cancer	0.012	0.0406	CbGpPWpGaD
Tazarotene—Leukoderma—Sunitinib—pancreatic cancer	0.0118	0.028	CcSEcCtD
Tazarotene—Cheilitis—Sunitinib—pancreatic cancer	0.0118	0.028	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.011	0.0374	CbGpPWpGaD
Tazarotene—Hypertriglyceridaemia—Tamoxifen—pancreatic cancer	0.0102	0.0242	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00986	0.0335	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Erlotinib—pancreatic cancer	0.00972	0.0231	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00946	0.0321	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00946	0.0321	CbGpPWpGaD
Tazarotene—Skin irritation—Fluorouracil—pancreatic cancer	0.00913	0.0217	CcSEcCtD
Tazarotene—Application site pain—Fluorouracil—pancreatic cancer	0.00897	0.0213	CcSEcCtD
Tazarotene—Blood triglycerides increased—Tamoxifen—pancreatic cancer	0.00892	0.0212	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Sunitinib—pancreatic cancer	0.00841	0.02	CcSEcCtD
Tazarotene—Blister—Tamoxifen—pancreatic cancer	0.0081	0.0192	CcSEcCtD
Tazarotene—Blister—Erlotinib—pancreatic cancer	0.00802	0.019	CcSEcCtD
Tazarotene—Blister—Sunitinib—pancreatic cancer	0.00694	0.0165	CcSEcCtD
Tazarotene—Acne—Erlotinib—pancreatic cancer	0.00687	0.0163	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Fluorouracil—pancreatic cancer	0.00664	0.0158	CcSEcCtD
Tazarotene—Inflammation—Tamoxifen—pancreatic cancer	0.00602	0.0143	CcSEcCtD
Tazarotene—Inflammation—Erlotinib—pancreatic cancer	0.00596	0.0142	CcSEcCtD
Tazarotene—Acne—Sunitinib—pancreatic cancer	0.00595	0.0141	CcSEcCtD
Tazarotene—Skin exfoliation—Tamoxifen—pancreatic cancer	0.00558	0.0132	CcSEcCtD
Tazarotene—Skin discolouration—Sunitinib—pancreatic cancer	0.00554	0.0132	CcSEcCtD
Tazarotene—Skin exfoliation—Erlotinib—pancreatic cancer	0.00552	0.0131	CcSEcCtD
Tazarotene—Blister—Fluorouracil—pancreatic cancer	0.00548	0.013	CcSEcCtD
Tazarotene—Sensitisation—Epirubicin—pancreatic cancer	0.00538	0.0128	CcSEcCtD
Tazarotene—Sensitisation—Doxorubicin—pancreatic cancer	0.00498	0.0118	CcSEcCtD
Tazarotene—Stinging—Fluorouracil—pancreatic cancer	0.00487	0.0116	CcSEcCtD
Tazarotene—Swelling—Tamoxifen—pancreatic cancer	0.00481	0.0114	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Docetaxel—pancreatic cancer	0.00479	0.0114	CcSEcCtD
Tazarotene—Skin exfoliation—Sunitinib—pancreatic cancer	0.00478	0.0113	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.00457	0.0155	CbGpPWpGaD
Tazarotene—Leukoderma—Epirubicin—pancreatic cancer	0.00452	0.0107	CcSEcCtD
Tazarotene—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.00444	0.0105	CcSEcCtD
Tazarotene—Dermatitis bullous—Erlotinib—pancreatic cancer	0.00439	0.0104	CcSEcCtD
Tazarotene—Leukoderma—Doxorubicin—pancreatic cancer	0.00418	0.00993	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.0041	0.0139	CbGpPWpGaD
Tazarotene—Burning sensation—Docetaxel—pancreatic cancer	0.0041	0.00974	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00409	0.0139	CbGpPWpGaD
Tazarotene—Inflammation—Fluorouracil—pancreatic cancer	0.00407	0.00967	CcSEcCtD
Tazarotene—Eczema—Sunitinib—pancreatic cancer	0.00404	0.0096	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.00393	0.0134	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.00393	0.0134	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00392	0.0133	CbGpPWpGaD
Tazarotene—Dermatitis contact—Fluorouracil—pancreatic cancer	0.0039	0.00927	CcSEcCtD
Tazarotene—Dry skin—Erlotinib—pancreatic cancer	0.00385	0.00913	CcSEcCtD
Tazarotene—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00383	0.0091	CcSEcCtD
Tazarotene—Dermatitis bullous—Sunitinib—pancreatic cancer	0.0038	0.00903	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00369	0.0125	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—PPARG—pancreatic cancer	0.00338	0.0115	CbGpPWpGaD
Tazarotene—Dry skin—Sunitinib—pancreatic cancer	0.00333	0.00791	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00331	0.0112	CbGpPWpGaD
Tazarotene—Swelling—Fluorouracil—pancreatic cancer	0.00325	0.00771	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Epirubicin—pancreatic cancer	0.00323	0.00767	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00317	0.0108	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00305	0.00724	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—PPARG—pancreatic cancer	0.00303	0.0103	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.003	0.00712	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Doxorubicin—pancreatic cancer	0.00299	0.0071	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00297	0.0101	CbGpPWpGaD
Tazarotene—Haemoglobin—Tamoxifen—pancreatic cancer	0.00295	0.007	CcSEcCtD
Tazarotene—Inflammation—Docetaxel—pancreatic cancer	0.00294	0.00698	CcSEcCtD
Tazarotene—Haemorrhage—Tamoxifen—pancreatic cancer	0.00293	0.00697	CcSEcCtD
Tazarotene—Haemoglobin—Erlotinib—pancreatic cancer	0.00292	0.00693	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors—PPARG—pancreatic cancer	0.0029	0.00986	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARG—pancreatic cancer	0.0029	0.00986	CbGpPWpGaD
Tazarotene—Haemorrhage—Erlotinib—pancreatic cancer	0.0029	0.00689	CcSEcCtD
Tazarotene—Oedema peripheral—Tamoxifen—pancreatic cancer	0.00289	0.00686	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00285	0.00968	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—AHR—pancreatic cancer	0.0028	0.00953	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—MET—pancreatic cancer	0.00279	0.00948	CbGpPWpGaD
Tazarotene—Burning sensation—Epirubicin—pancreatic cancer	0.00277	0.00657	CcSEcCtD
Tazarotene—Skin exfoliation—Docetaxel—pancreatic cancer	0.00272	0.00646	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00267	0.00906	CbGpPWpGaD
Tazarotene—Blister—Epirubicin—pancreatic cancer	0.00267	0.00633	CcSEcCtD
Tazarotene—Dry skin—Fluorouracil—pancreatic cancer	0.00263	0.00624	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.0026	0.00884	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGF—pancreatic cancer	0.0026	0.00882	CbGpPWpGaD
Tazarotene—Burning sensation—Doxorubicin—pancreatic cancer	0.00256	0.00608	CcSEcCtD
Tazarotene—Erythema—Tamoxifen—pancreatic cancer	0.00255	0.00607	CcSEcCtD
Tazarotene—Erythema—Erlotinib—pancreatic cancer	0.00253	0.006	CcSEcCtD
Tazarotene—Haemoglobin—Sunitinib—pancreatic cancer	0.00253	0.006	CcSEcCtD
Tazarotene—Haemorrhage—Sunitinib—pancreatic cancer	0.00251	0.00597	CcSEcCtD
Tazarotene—Oedema peripheral—Sunitinib—pancreatic cancer	0.00248	0.00588	CcSEcCtD
Tazarotene—Blister—Doxorubicin—pancreatic cancer	0.00247	0.00586	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.00243	0.00825	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—pancreatic cancer	0.00242	0.00821	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00239	0.00813	CbGpPWpGaD
Tazarotene—Stinging—Epirubicin—pancreatic cancer	0.00237	0.00563	CcSEcCtD
Tazarotene—Swelling—Docetaxel—pancreatic cancer	0.00234	0.00557	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.00233	0.00792	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00229	0.00779	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00229	0.00779	CbGpPWpGaD
Tazarotene—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00226	0.00537	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.00224	0.0076	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.00224	0.0076	CbGpPWpGaD
Tazarotene—Stinging—Doxorubicin—pancreatic cancer	0.00219	0.00521	CcSEcCtD
Tazarotene—Erythema—Sunitinib—pancreatic cancer	0.00219	0.00519	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.00218	0.0074	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00216	0.00514	CcSEcCtD
Tazarotene—Discomfort—Tamoxifen—pancreatic cancer	0.00215	0.0051	CcSEcCtD
Tazarotene—Skin discolouration—Epirubicin—pancreatic cancer	0.00213	0.00505	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.00209	0.00712	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.00209	0.00709	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.00209	0.00709	CbGpPWpGaD
Tazarotene—Oedema—Tamoxifen—pancreatic cancer	0.00208	0.00495	CcSEcCtD
Tazarotene—Haemoglobin—Irinotecan—pancreatic cancer	0.00208	0.00494	CcSEcCtD
Tazarotene—RARA—Adipogenesis—GADD45A—pancreatic cancer	0.00208	0.00706	CbGpPWpGaD
Tazarotene—Haemorrhage—Irinotecan—pancreatic cancer	0.00207	0.00492	CcSEcCtD
Tazarotene—Oedema—Erlotinib—pancreatic cancer	0.00206	0.0049	CcSEcCtD
Tazarotene—Haemoglobin—Gemcitabine—pancreatic cancer	0.00203	0.00481	CcSEcCtD
Tazarotene—Haemorrhage—Gemcitabine—pancreatic cancer	0.00202	0.00479	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.00201	0.00682	CbGpPWpGaD
Tazarotene—Haemoglobin—Fluorouracil—pancreatic cancer	0.00199	0.00473	CcSEcCtD
Tazarotene—Oedema peripheral—Gemcitabine—pancreatic cancer	0.00199	0.00472	CcSEcCtD
Tazarotene—Haemorrhage—Fluorouracil—pancreatic cancer	0.00198	0.00471	CcSEcCtD
Tazarotene—Inflammation—Epirubicin—pancreatic cancer	0.00198	0.00471	CcSEcCtD
Tazarotene—Skin discolouration—Doxorubicin—pancreatic cancer	0.00197	0.00468	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.0019	0.00645	CbGpPWpGaD
Tazarotene—Dermatitis contact—Epirubicin—pancreatic cancer	0.0019	0.00451	CcSEcCtD
Tazarotene—Dry skin—Docetaxel—pancreatic cancer	0.0019	0.0045	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.00188	0.00638	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00186	0.0063	CbGpPWpGaD
Tazarotene—Skin exfoliation—Epirubicin—pancreatic cancer	0.00183	0.00436	CcSEcCtD
Tazarotene—Inflammation—Doxorubicin—pancreatic cancer	0.00183	0.00435	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.0018	0.00612	CbGpPWpGaD
Tazarotene—Oedema—Sunitinib—pancreatic cancer	0.00179	0.00424	CcSEcCtD
Tazarotene—Pain—Tamoxifen—pancreatic cancer	0.00178	0.00423	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00178	0.00604	CbGpPWpGaD
Tazarotene—Pain—Erlotinib—pancreatic cancer	0.00176	0.00419	CcSEcCtD
Tazarotene—Dermatitis contact—Doxorubicin—pancreatic cancer	0.00176	0.00417	CcSEcCtD
Tazarotene—Erythema—Gemcitabine—pancreatic cancer	0.00175	0.00417	CcSEcCtD
Tazarotene—Erythema—Fluorouracil—pancreatic cancer	0.00173	0.0041	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.0017	0.00579	CbGpPWpGaD
Tazarotene—Skin exfoliation—Doxorubicin—pancreatic cancer	0.0017	0.00403	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00163	0.00555	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00163	0.00555	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00162	0.00551	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.00161	0.00548	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00159	0.00542	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00156	0.00528	CbGpPWpGaD
Tazarotene—Eczema—Epirubicin—pancreatic cancer	0.00155	0.00369	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00153	0.00519	CbGpPWpGaD
Tazarotene—Pain—Sunitinib—pancreatic cancer	0.00153	0.00363	CcSEcCtD
Tazarotene—Discomfort—Irinotecan—pancreatic cancer	0.00152	0.0036	CcSEcCtD
Tazarotene—Discomfort—Gemcitabine—pancreatic cancer	0.00148	0.00351	CcSEcCtD
Tazarotene—Pruritus—Tamoxifen—pancreatic cancer	0.00147	0.0035	CcSEcCtD
Tazarotene—Oedema—Irinotecan—pancreatic cancer	0.00147	0.00349	CcSEcCtD
Tazarotene—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00146	0.00347	CcSEcCtD
Tazarotene—Pruritus—Erlotinib—pancreatic cancer	0.00146	0.00347	CcSEcCtD
Tazarotene—Discomfort—Fluorouracil—pancreatic cancer	0.00145	0.00345	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.00145	0.00491	CbGpPWpGaD
Tazarotene—Haemoglobin—Docetaxel—pancreatic cancer	0.00144	0.00342	CcSEcCtD
Tazarotene—Eczema—Doxorubicin—pancreatic cancer	0.00144	0.00341	CcSEcCtD
Tazarotene—Oedema—Gemcitabine—pancreatic cancer	0.00143	0.0034	CcSEcCtD
Tazarotene—Haemorrhage—Docetaxel—pancreatic cancer	0.00143	0.0034	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.00142	0.00481	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—pancreatic cancer	0.00141	0.0048	CbGpPWpGaD
Tazarotene—Oedema peripheral—Docetaxel—pancreatic cancer	0.00141	0.00335	CcSEcCtD
Tazarotene—Oedema—Fluorouracil—pancreatic cancer	0.00141	0.00334	CcSEcCtD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.00139	0.00471	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—pancreatic cancer	0.00139	0.00471	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.00137	0.00464	CbGpPWpGaD
Tazarotene—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.00135	0.00321	CcSEcCtD
Tazarotene—Rash—Tamoxifen—pancreatic cancer	0.00131	0.00312	CcSEcCtD
Tazarotene—Dermatitis—Tamoxifen—pancreatic cancer	0.00131	0.00312	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.00131	0.00445	CbGpPWpGaD
Tazarotene—Rash—Erlotinib—pancreatic cancer	0.0013	0.00309	CcSEcCtD
Tazarotene—Dermatitis—Erlotinib—pancreatic cancer	0.0013	0.00309	CcSEcCtD
Tazarotene—Dry skin—Epirubicin—pancreatic cancer	0.00128	0.00304	CcSEcCtD
Tazarotene—RARA—Adipogenesis—HIF1A—pancreatic cancer	0.00128	0.00434	CbGpPWpGaD
Tazarotene—Pruritus—Sunitinib—pancreatic cancer	0.00126	0.003	CcSEcCtD
Tazarotene—Pain—Irinotecan—pancreatic cancer	0.00126	0.00299	CcSEcCtD
Tazarotene—Erythema—Docetaxel—pancreatic cancer	0.00125	0.00296	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.00123	0.00419	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—pancreatic cancer	0.00123	0.00417	CbGpPWpGaD
Tazarotene—Pain—Gemcitabine—pancreatic cancer	0.00122	0.00291	CcSEcCtD
Tazarotene—Pain—Fluorouracil—pancreatic cancer	0.0012	0.00286	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.0012	0.00406	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.00118	0.00402	CbGpPWpGaD
Tazarotene—Dry skin—Doxorubicin—pancreatic cancer	0.00118	0.00281	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00117	0.00399	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.00115	0.00389	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—pancreatic cancer	0.00114	0.00386	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00113	0.00383	CbGpPWpGaD
Tazarotene—Rash—Sunitinib—pancreatic cancer	0.00113	0.00267	CcSEcCtD
Tazarotene—Dermatitis—Sunitinib—pancreatic cancer	0.00112	0.00267	CcSEcCtD
Tazarotene—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.0011	0.00261	CcSEcCtD
Tazarotene—RARG—Gene Expression—CHD3—pancreatic cancer	0.00109	0.00371	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00109	0.00371	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARG—pancreatic cancer	0.00109	0.00369	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—RB1—pancreatic cancer	0.00104	0.00353	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.00103	0.00351	CbGpPWpGaD
Tazarotene—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00102	0.00242	CcSEcCtD
Tazarotene—Oedema—Docetaxel—pancreatic cancer	0.00102	0.00241	CcSEcCtD
Tazarotene—Pruritus—Gemcitabine—pancreatic cancer	0.00101	0.00241	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—pancreatic cancer	0.001	0.00341	CbGpPWpGaD
Tazarotene—Pruritus—Fluorouracil—pancreatic cancer	0.000996	0.00237	CcSEcCtD
Tazarotene—RARB—Gene Expression—CHD3—pancreatic cancer	0.000979	0.00332	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000978	0.00332	CbGpPWpGaD
Tazarotene—Haemoglobin—Epirubicin—pancreatic cancer	0.00097	0.0023	CcSEcCtD
Tazarotene—Haemorrhage—Epirubicin—pancreatic cancer	0.000965	0.00229	CcSEcCtD
Tazarotene—Oedema peripheral—Epirubicin—pancreatic cancer	0.000951	0.00226	CcSEcCtD
Tazarotene—RARA—Gene Expression—CHD3—pancreatic cancer	0.000938	0.00319	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CHD3—pancreatic cancer	0.000938	0.00319	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000938	0.00319	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000938	0.00319	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000928	0.00315	CbGpPWpGaD
Tazarotene—Rash—Irinotecan—pancreatic cancer	0.000927	0.0022	CcSEcCtD
Tazarotene—Dermatitis—Irinotecan—pancreatic cancer	0.000926	0.0022	CcSEcCtD
Tazarotene—RARG—Gene Expression—NR5A2—pancreatic cancer	0.000914	0.00311	CbGpPWpGaD
Tazarotene—Rash—Gemcitabine—pancreatic cancer	0.000903	0.00214	CcSEcCtD
Tazarotene—Dermatitis—Gemcitabine—pancreatic cancer	0.000902	0.00214	CcSEcCtD
Tazarotene—Haemoglobin—Doxorubicin—pancreatic cancer	0.000897	0.00213	CcSEcCtD
Tazarotene—Haemorrhage—Doxorubicin—pancreatic cancer	0.000893	0.00212	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.00089	0.00302	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000889	0.00302	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000889	0.00302	CbGpPWpGaD
Tazarotene—Rash—Fluorouracil—pancreatic cancer	0.000888	0.00211	CcSEcCtD
Tazarotene—Dermatitis—Fluorouracil—pancreatic cancer	0.000887	0.00211	CcSEcCtD
Tazarotene—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00088	0.00209	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000879	0.00299	CbGpPWpGaD
Tazarotene—Pain—Docetaxel—pancreatic cancer	0.000869	0.00206	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000853	0.0029	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000852	0.00289	CbGpPWpGaD
Tazarotene—Erythema—Epirubicin—pancreatic cancer	0.00084	0.002	CcSEcCtD
Tazarotene—RARB—Gene Expression—NR5A2—pancreatic cancer	0.00082	0.00279	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000817	0.00278	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000789	0.00268	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR5A2—pancreatic cancer	0.000786	0.00267	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR5A2—pancreatic cancer	0.000786	0.00267	CbGpPWpGaD
Tazarotene—Erythema—Doxorubicin—pancreatic cancer	0.000777	0.00185	CcSEcCtD
Tazarotene—RARA—Adipogenesis—CTNNB1—pancreatic cancer	0.000764	0.00259	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000756	0.00257	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000756	0.00257	CbGpPWpGaD
Tazarotene—Pruritus—Docetaxel—pancreatic cancer	0.000719	0.00171	CcSEcCtD
Tazarotene—Discomfort—Epirubicin—pancreatic cancer	0.000707	0.00168	CcSEcCtD
Tazarotene—Oedema—Epirubicin—pancreatic cancer	0.000686	0.00163	CcSEcCtD
Tazarotene—RARA—Adipogenesis—STAT3—pancreatic cancer	0.000666	0.00226	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000662	0.00225	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000654	0.00222	CbGpPWpGaD
Tazarotene—Discomfort—Doxorubicin—pancreatic cancer	0.000654	0.00155	CcSEcCtD
Tazarotene—Rash—Docetaxel—pancreatic cancer	0.000641	0.00152	CcSEcCtD
Tazarotene—Dermatitis—Docetaxel—pancreatic cancer	0.00064	0.00152	CcSEcCtD
Tazarotene—Oedema—Doxorubicin—pancreatic cancer	0.000634	0.00151	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000627	0.00213	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—pancreatic cancer	0.000617	0.0021	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000608	0.00206	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000594	0.00202	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000591	0.00201	CbGpPWpGaD
Tazarotene—Pain—Epirubicin—pancreatic cancer	0.000586	0.00139	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000586	0.00199	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000582	0.00198	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—pancreatic cancer	0.000576	0.00196	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000571	0.00194	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000569	0.00193	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000569	0.00193	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000567	0.00193	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000561	0.00191	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000547	0.00186	CbGpPWpGaD
Tazarotene—Pain—Doxorubicin—pancreatic cancer	0.000542	0.00129	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000529	0.0018	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MEN1—pancreatic cancer	0.000525	0.00178	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000516	0.00175	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000507	0.00172	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH4—pancreatic cancer	0.000498	0.00169	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000494	0.00168	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000488	0.00166	CbGpPWpGaD
Tazarotene—Pruritus—Epirubicin—pancreatic cancer	0.000485	0.00115	CcSEcCtD
Tazarotene—RARG—Gene Expression—HSPA1B—pancreatic cancer	0.000475	0.00161	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000474	0.00161	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000473	0.00161	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MEN1—pancreatic cancer	0.000471	0.0016	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000464	0.00158	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000461	0.00157	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000455	0.00154	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000454	0.00154	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MEN1—pancreatic cancer	0.000452	0.00153	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MEN1—pancreatic cancer	0.000452	0.00153	CbGpPWpGaD
Tazarotene—Pruritus—Doxorubicin—pancreatic cancer	0.000449	0.00107	CcSEcCtD
Tazarotene—RARB—Gene Expression—NOTCH4—pancreatic cancer	0.000447	0.00152	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000445	0.00151	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000442	0.0015	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000438	0.00149	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000438	0.00149	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000438	0.00149	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EZH2—pancreatic cancer	0.000433	0.00147	CbGpPWpGaD
Tazarotene—Rash—Epirubicin—pancreatic cancer	0.000432	0.00103	CcSEcCtD
Tazarotene—Dermatitis—Epirubicin—pancreatic cancer	0.000432	0.00103	CcSEcCtD
Tazarotene—RARA—Gene Expression—NOTCH4—pancreatic cancer	0.000428	0.00145	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH4—pancreatic cancer	0.000428	0.00145	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPA1B—pancreatic cancer	0.000426	0.00145	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000424	0.00144	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH3—pancreatic cancer	0.000423	0.00144	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.00042	0.00143	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.00042	0.00143	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.00042	0.00143	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000413	0.0014	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPA1B—pancreatic cancer	0.000408	0.00139	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPA1B—pancreatic cancer	0.000408	0.00139	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000403	0.00137	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPA1A—pancreatic cancer	0.000401	0.00136	CbGpPWpGaD
Tazarotene—Rash—Doxorubicin—pancreatic cancer	0.0004	0.00095	CcSEcCtD
Tazarotene—Dermatitis—Doxorubicin—pancreatic cancer	0.0004	0.000949	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000396	0.00135	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000396	0.00135	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.00039	0.00132	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—EZH2—pancreatic cancer	0.000388	0.00132	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000386	0.00131	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH3—pancreatic cancer	0.00038	0.00129	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000373	0.00127	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EZH2—pancreatic cancer	0.000372	0.00126	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EZH2—pancreatic cancer	0.000372	0.00126	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH3—pancreatic cancer	0.000364	0.00124	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH3—pancreatic cancer	0.000364	0.00124	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPA1A—pancreatic cancer	0.00036	0.00122	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPA1A—pancreatic cancer	0.000345	0.00117	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPA1A—pancreatic cancer	0.000345	0.00117	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000329	0.00112	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SMAD4—pancreatic cancer	0.000319	0.00108	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000315	0.00107	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SMAD4—pancreatic cancer	0.000286	0.000972	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SMAD4—pancreatic cancer	0.000274	0.000931	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SMAD4—pancreatic cancer	0.000274	0.000931	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—pancreatic cancer	0.000263	0.000892	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000236	0.0008	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH1—pancreatic cancer	0.000235	0.000798	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000226	0.000767	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—pancreatic cancer	0.000226	0.000767	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—pancreatic cancer	0.000222	0.000754	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH1—pancreatic cancer	0.000211	0.000716	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH1—pancreatic cancer	0.000202	0.000687	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH1—pancreatic cancer	0.000202	0.000687	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—pancreatic cancer	0.000199	0.000676	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—pancreatic cancer	0.000191	0.000648	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—pancreatic cancer	0.000191	0.000648	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PRSS1—pancreatic cancer	0.000146	0.000497	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ARG2—pancreatic cancer	0.000127	0.000431	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—pancreatic cancer	0.000126	0.00043	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—pancreatic cancer	0.000113	0.000385	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TYMP—pancreatic cancer	0.000111	0.000376	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—pancreatic cancer	0.000109	0.000369	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—pancreatic cancer	0.000109	0.000369	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.14e-05	0.000311	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GLP1R—pancreatic cancer	8.93e-05	0.000303	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DPYD—pancreatic cancer	8.78e-05	0.000298	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—pancreatic cancer	8.77e-05	0.000298	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	8.34e-05	0.000283	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.25e-05	0.00028	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.96e-05	0.00027	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—pancreatic cancer	7.87e-05	0.000267	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—pancreatic cancer	7.54e-05	0.000256	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—pancreatic cancer	7.54e-05	0.000256	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.25e-05	0.000246	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD44—pancreatic cancer	6.46e-05	0.000219	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.32e-05	0.000215	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.26e-05	0.000213	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCG—pancreatic cancer	6.19e-05	0.00021	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—STK11—pancreatic cancer	5.82e-05	0.000198	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.46e-05	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TYMS—pancreatic cancer	5.01e-05	0.00017	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOE—pancreatic cancer	4.07e-05	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.85e-05	0.000131	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.67e-05	0.000125	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.55e-05	0.00012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.23e-05	0.00011	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.82e-05	9.56e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.79e-05	9.48e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.43e-05	8.26e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.72e-05	5.83e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.4e-05	4.76e-05	CbGpPWpGaD
